Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Targeting the mTOR signaling pathway in neuroendocrine tumors.

Targeting the mTOR signaling pathway in neuroendocrine tumors. Curr Treat Options Oncol. 2014 Sep; 15(3):365-79.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.